Gene: SMIM29
Official Full Name: small integral membrane protein 29provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27485 | SMIM29 Knockout cell line (HeLa) | Human | SMIM29 | 1:3~1:6 | Negative | Online Inquiry |
KO27486 | SMIM29 Knockout cell line (HCT 116) | Human | SMIM29 | 1:2~1:4 | Negative | Online Inquiry |
KO27487 | SMIM29 Knockout cell line (HEK293) | Human | SMIM29 | 1:3~1:6 | Negative | Online Inquiry |
KO27488 | SMIM29 Knockout cell line (A549) | Human | SMIM29 | 1:3~1:4 | Negative | Online Inquiry |
SMIM29 Gene Knockout Cell Lines are specially engineered cellular models that have undergone precise gene editing to completely disable the SMIM29 gene, a crucial gene implicated in various cellular processes and disease states. These knockout cell lines are pivotal for researchers exploring the functional roles of SMIM29 in biological pathways, allowing for a detailed understanding of its contribution to cellular physiology and pathology.
The core mechanism behind these cell lines hinges on CRISPR/Cas9 technology, which facilitates the targeted disruption of the SMIM29 gene. This approach not only ensures high specificity but also results in stable genetic modifications within the cell lines, offering a reliable platform for downstream analyses. These models enable researchers to investigate gene function, elucidate signaling pathways, and assess therapeutic targets in disease contexts, thus accelerating discoveries in fundamental and applied biological research.
The scientific importance of SMIM29 Knockout Cell Lines extends into both research and clinical applications. These models allow for the examination of gene interactions and cellular responses in conditions such as cancer, cardiovascular diseases, and genetic disorders. Leveraging these knockout lines can reveal unique insights that are critical for developing targeted therapies and personalized medicine strategies.
Compared to other gene knockout approaches, the SMIM29 Gene Knockout Cell Lines provide enhanced reproducibility and efficiency, minimizing off-target effects commonly associated with alternative methods. Furthermore, these cell lines are optimized for versatility, making them suitable for a range of experimental setups, including drug screening, gene expression analyses, and pathway elucidation.
For researchers and clinicians alike, the value of SMIM29 Gene Knockout Cell Lines lies not only in their scientific accuracy but also in their role in driving innovative research forward. By utilizing these cell lines, professionals can save time and resource allocations while obtaining reliable data that contribute significantly to the body of knowledge in genetics and molecular biology.
With extensive expertise in biological research products and a commitment to quality, our company specializes in providing advanced genetic tools that empower the scientific community to achieve groundbreaking research and therapeutic advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.